|
|
|
Recommended Books
|
The Innovator's Prescription
A Disruptive Solution for Health Care
Clayton M. Christensen, professor of Business Administration at Harvard Business School, Jerome H. Grossman, Director of the Harvard Kennedy School Health Care Delivery Policy Program, and Jason Hwang, an internal medicine physician and Senior Strategist for the Healthcare Practice at Innosight, teamed to write this book on how the American healthcare system can be effectively disrupted in order to deliver better care at reduced cost. They argue that a new model combining solution shops to diagnose complex cases, value-adding process hospitals and clinics to deliver procedural care, and facilitated patient networks to address chronic disease care, could be the sustainable solution for the health care system.
|
|
Redefining Health Care
Creating Value-Based Competition on Results
Written by Michael Porter and Elizabeth Olmsted Teisberg, Redefining Health Care looks to reestablish the concept of value within the U.S. healthcare system. With the cost of services shielded from consumers and a general lack of competition within the healthcare delivery system, costs have spiraled upward without necessarily a commensurate increase in value. Redefining Health Care dissects this complex problem and provides guidance for possible solutions.
|
|
Overtreated
Why too Much Medicine is Making Us Sicker and Poorer
David Leonhardt, economics writer for The New York Times, named Overtreated by Shannon Brownlee his economics book of the year in 2007. The book is extremely interesting and well written. One of Brownlee’s primary points is that healthcare has a unique market system based on “supply-driven demand.” Research has consistently shown that increased facilities and services leads to greater utilization, much of which is unnecessary.
|
|
Overdosed America
The Broken Promise of American Medicine
John Abramson was a family physician who left his practice to write this book on the businesses practices of pharmaceutical companies. The industry has changed dramatically as pharmaceutical companies began advertising directly to consumers and as the companies increasingly paid universities and doctors directly for research studies. Using his background in statistics, Abramson questions the relative value of many of the blockbuster drugs pharmaceutical companies sell.
|
|
|
|
